NCT06090513View on ClinicalTrials.gov

Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 18, 2024

Primary Completion Date

October 18, 2025

Study Completion Date

October 18, 2026

Conditions
Advanced CancerSolid Tumor, AdultMyeloid Malignancy
Interventions
COMBINATION_PRODUCT

Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation

TSO500; detect single nucleotide variants (SNV), INDELs, copy number alterations (CNAs), microsatellite instability (MSI), and tumor mutation burden (TMB) in eligible patients; ELIA software to interface clinic EMR to lab; Consultations and molecular tumor boards by molecular genetic pathologist (MGP)

DIAGNOSTIC_TEST

limited genetic testing or no testing

Minimal genetic testing for eligible patients or treatment without testing

Trial Locations (1)

29732

Carolina Blood and Cancer Care Associates, Rock Hill

All Listed Sponsors
collaborator

No One Left Alone

UNKNOWN

collaborator

Carolina Blood and Cancer Care Associates

UNKNOWN

lead

Bien-Willner Physicians Group PA

OTHER

NCT06090513 - Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients | Biotech Hunter | Biotech Hunter